Trevi Therapeutics
TRVI
#6350
Rank
A$0.96 B
Marketcap
$10.01
Share price
-2.73%
Change (1 day)
111.97%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$72.72 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$47.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -A$79.29 Million67%
2023 -A$47.48 Million2.43%
2022 -A$46.36 Million-14.45%
2021 -A$54.19 Million1.36%
2020 -A$53.46 Million23.64%
2019 -A$43.24 Million27.54%
2018 -A$33.9 Million